Form 4: Natera Director Sells Shares Under 10b5-1 Plan

Natera Director Rowan E. Chapman sold 122 shares of common stock for $191.38 per share under a pre-arranged 10b5-1 trading plan.

Summary

• Rowan E. Chapman, a Director of Natera, Inc. (NTRA), reported a sale of company common stock.
• The transaction involved the disposition of 122 shares.
• The shares were sold at a price of $191.38 per share.
• Following this transaction, Chapman beneficially owns 5,752 shares of Natera common stock directly.
• The sale was executed on March 13, 2026, pursuant to a Rule 10b5-1 trading plan adopted on December 12, 2025.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event. Insider sales under a 10b5-1 plan are typically pre-scheduled and do not necessarily indicate a change in the insider's confidence in the company's future performance.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that insider sales under a 10b5-1 plan are pre-scheduled and often do not reflect a change in management's immediate outlook on the company's prospects, distinguishing them from opportunistic sales.

Stakeholder Impact

• Shareholders: The sale represents a minor reduction in direct ownership by a director, but as it's under a 10b5-1 plan, it's generally not seen as a negative signal.

Key Dates

Recommendation

The sale of shares by a director was conducted under a pre-arranged Rule 10b5-1 trading plan, which is a common practice for insiders to diversify holdings or manage liquidity without implying a negative outlook on the company. This transaction alone does not provide sufficient new information to alter an existing investment thesis for Natera, Inc.

Keywords

Natera, NTRA, Form 4, Insider Trading, Stock Sale, Director, 10b5-1 Plan, Common Stock